Alan D. Wickenden

3.8k citations

61 papers · 3.1k indexed · h-index 34

Impact in

Cellular and Molecular Neuroscience top 2%
- Neuroscience and Neuropharmacology Research
Sensory Systems top 1%
- Ion Channels and Receptors

Papers in

Sensory Systems 8
- Ion Channels and Receptors 8
Cellular and Molecular Neuroscience 23
- Neuroscience and Neuropharmacology Research 18

Co-authors: Peter H. Backx Timothy Jegla P. Kay Wagoner Roger Kaprielian Sandra R. Chaplan Weifeng Yu Thomas G. Parker Tue G. Banke
Journals: Bioorganic & Medicinal Chemistry Letters (5 papers)Molecular Pharmacology (5 papers)Journal of Biological Chemistry (5 papers)British Journal of Pharmacology (5 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Alan D. Wickenden

60 papers receiving 3.0k citations

Peers

Countries citing papers authored by Alan D. Wickenden

Since Specialization

Citations

This map shows the geographic impact of Alan D. Wickenden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan D. Wickenden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan D. Wickenden more than expected).

Fields of papers citing papers by Alan D. Wickenden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan D. Wickenden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan D. Wickenden. The network helps show where Alan D. Wickenden may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan D. Wickenden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan D. Wickenden Line = papers co-authored together Alan D. Wickenden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa_v1.7 Journal of Biological Chemistry ·Robert A. Neff, M.L. Flinspach, Alan C. Gibbs, Amy Y. Shih, Natali A. Minassian, Yi Liu, Martha Miller, Ondrej Libiger, Stephanie Young, Michael W. Pennington, Michael J. Hunter, Alan D. Wickenden	2019	17
2	Potentiating SLC transporter activity: Emerging drug discovery opportunities Biochemical Pharmacology ·M. Rives, Jonathan A. Javitch, Alan D. Wickenden	2017	54
3	T Cell Subset and Stimulation Strength-Dependent Modulation of T Cell Activation by Kv1.3 Blockers PLoS ONE ·Wai‐Ping Fung‐Leung, Wilson B. Edwards, Yi Liu, Karen Ngo, Julianty Angsana, Glenda Castro, Nancy Wu, Xuejun Liu, Ronald V. Swanson, Alan D. Wickenden	2017	14
4	Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor Scientific Reports ·M.L. Flinspach, Q. Xu, Andrew D. Piekarz, Martha Miller, F Wang, Alan C. Gibbs, Vivien Pavelka, Robert A. Neff, Jacob Freedman, William A. Eckert, Mei Zhou, Cristiano Barbieri, Michael W. Pennington, Kelly A. Eddinger, Tony L. Yaksh, M Hunter, Mi Suk Kim, Alan D. Wickenden	2017	93
5	State-Dependent Allosteric Inhibition of the Human SLC13A5 Citrate Transporter by Hydroxysuccinic Acids, PF-06649298 and PF-06761281 Molecular Pharmacology ·M. Rives, Alan Platt, Bin Zhu, Simon A. Hinke, Alan D. Wickenden	2016	13
6	The discovery and preclinical characterization of 6-chloro-N-(2-(4,4-difluoropiperidin-1-yl)-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethyl)quinoline-5-carboxamide based P2X7 antagonists Bioorganic & Medicinal Chemistry Letters ·Jason C. Rech, Anindya Bhattacharya, 尚夫志村, Christopher J. Love, Feti Munika Sakti, Gregory M Ngahu, William A. Eckert, Hong Ao, Qi Wang, Sandra R. Chaplan, Alan D. Wickenden, Alec D. Lebsack, J. Guy Breitenbucher	2016	7
7	Targeting the Ion Channel Kv1.3 with Scorpion Venom Peptides Engineered for Potency, Selectivity, and Half-life Journal of Biological Chemistry ·Wilson B. Edwards, Wai‐Ping Fung‐Leung, Chichi Huang, Ellen Chi, Nancy Wu, Yi Liu, Michael P. Maher, Shannon Gaasch, DO Katherine Fisher, Martha Miller, Occa Roanisca, Jerry Lee, Lu Lu, Karen Ngo, Brian Scott, Hong Zhou, Ronald V. Swanson, Alan D. Wickenden	2014	26
8	Analysis of the Structural and Molecular Basis of Voltage-sensitive Sodium Channel Inhibition by the Spider Toxin Huwentoxin-IV (μ-TRTX-Hh2a) Journal of Biological Chemistry ·Natali A. Minassian, Alan C. Gibbs, Amy Y. Shih, Yi Liu, Robert A. Neff, Steven W. Sutton, Tara Mirzadegan, DO Katherine Fisher, Martha Miller, Yanbo Shao, Sheina A. Duncan, Michael J. Hunter, M.L. Flinspach, Alan D. Wickenden	2013	61
9	Discovery of a novel series of selective HCN1 blockers Bioorganic & Medicinal Chemistry Letters ·Kelly J. McClure, Michael P. Maher, Nancy Wu, Sandra R. Chaplan, William A. Eckert, Hwihanus Hwihanus, Alan D. Wickenden, 刘相生, Brett D. Allison, Natalie A. Hawryluk, J. Guy Breitenbucher, Cheryl A. Grice	2011	25
10	A novel TRPV1 receptor antagonist JNJ-17203212 attenuates colonichypersensitivity in rats Methods and Findings in Experimental and Clinical Pharmacology ·Brandt Wiskur, Kevin M. Tyler, Diska Anjali Lubis, Sandra R. Chaplan, Alan D. Wickenden, B. Greenwood-Van Meerveld	2010	16
11	In Vivo Profile of ICA-27243 [N-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a Potent and Selective KCNQ2/Q3 (Kv7.2/Kv7.3) Activator in Rodent Anticonvulsant Models Journal of Pharmacology and Experimental Therapeutics ·Rosemarie Roeloffs, Alan D. Wickenden, Christopher Crean, 下山芳江, Grant McNaughton‐Smith, James P. Stables, James O McNamara, Neil Ghodadra, Greg C. Rigdon	2008	54
12	Pharmacology and Antitussive Efficacy of 4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic Acid (5-Trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a Transient Receptor Potential Vanilloid 1 Antagonist in Guinea Pigs Journal of Pharmacology and Experimental Therapeutics ·Anindya Bhattacharya, Brian Scott, Nadia Nasser, Hong Ao, Michael P. Maher, Adrienne E. Dubin, Devin M. Swanson, Nigel P. Shankley, Alan D. Wickenden, Sandra R. Chaplan	2007	62
13	N-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): A Novel, Selective KCNQ2/Q3 Potassium Channel Activator Molecular Pharmacology ·Alan D. Wickenden, John R.Vile, Barry London, P. Kay Wagoner, W. A. Wilson, Suzanne Clark, Rosemarie Roeloffs, Grant McNaughton‐Smith, Greg C. Rigdon	2007	99
14	Potassium channels as anti-epileptic drug targets Neuropharmacology ·Alan D. Wickenden	2002	68
15	Relationship between K⁺ channel down‐regulation and [Ca²⁺]_i in rat ventricular myocytes following myocardial infarction The Journal of Physiology ·Roger Kaprielian, Alan D. Wickenden, Zamaneh Kassiri, Thomas G. Parker, Nadine M. Hammoud, Peter H. Backx	1999	122
16	Effect of Cd<sup>2+</sup> on Kv4.2 and Kv1.4 Expressed in <i>Xenopus</i> Oocytes and on the Transient Outward Currents in Rat and Rabbit Ventricular Myocytes Cellular Physiology and Biochemistry ·Alan D. Wickenden, Robert G. Tsushima, Li. Tchon, Roger Kaprielian, Peter H. Backx	1999	33
17	Effects of Development and Thyroid Hormone on K⁺ Currents and K⁺ Channel Gene Expression in Rat Ventricle The Journal of Physiology ·Alan D. Wickenden, Roger Kaprielian, Thomas G. Parker, Owen Jones, Peter H. Backx	1997	123
18	Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin‐induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestat British Journal of Pharmacology ·Paul Taylor, Alan D. Wickenden, Donald J. Mirrlees, Lucilla Poston	1994	60
19	Comparison of the effects of the K⁺‐channel openers cromakalim and minoxidil sulphate on vascular smooth muscle British Journal of Pharmacology ·Alan D. Wickenden, S. Grimwood, Lars M. Hübschle, Yi Su	1991	30
20	The physiological relevance of low agonist affinity binding at opioid μ‐receptors British Journal of Pharmacology ·Algifari Muhammad, John S. Shaw, Alan D. Wickenden	1988	35

About Alan D. Wickenden

Alan D. Wickenden is a scholar working on Sensory Systems, Cellular and Molecular Neuroscience, Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology, having authored 61 papers that have together received 3.1k indexed citations. Recurring topics across this work include Ion channel regulation and function (41 papers), Cardiac electrophysiology and arrhythmias (28 papers), Neuroscience and Neuropharmacology Research (18 papers), Ion Channels and Receptors (8 papers), Nicotinic Acetylcholine Receptors Study (8 papers), Receptor Mechanisms and Signaling (5 papers), Cardiomyopathy and Myosin Studies (5 papers) and Pain Mechanisms and Treatments (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.1k citations), Sensory Systems (272 citations), Cardiology and Cardiovascular Medicine (1.1k citations), Physiology (210 citations) and Molecular Biology (2.0k citations). Alan D. Wickenden has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Peter H. Backx, Timothy Jegla, P. Kay Wagoner, Roger Kaprielian, Sandra R. Chaplan, Weifeng Yu, Thomas G. Parker, Tue G. Banke, Grant McNaughton‐Smith and Rajan Sah. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Molecular Pharmacology, Journal of Biological Chemistry, British Journal of Pharmacology and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact